Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Cell Biochem ; 477(5): 1329-1338, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35138513

RESUMEN

Inflammation contributes to the pathogenesis of liver disease, and inflammasome activation has been identified as a major contributor to the amplification of liver inflammation. Transforming growth factor-beta (TGF-ß) is a key regulator of liver physiology, contributing to all stages of liver disease. We investigated whether TGF-ß is involved in inflammasome-mediated fibrosis in hepatic stellate cells. Treatment with TGF-ß increased priming of NLRP3 inflammasome signaling by increasing NLRP3 levels and activating TAK1-NF-kB signaling. Moreover, TGF-ß increased the expression of p-Smad2/3-NOX4 in LX-2 cells and consequently increased ROS content, which is a trigger for NLRP3 inflammasome activation. Elevated expression of NEK7 and active caspase-1 was also shown in TGF-ß-induced LX-2 cells, and this level was reduced by (5Z)-oxozeaenol, a TAK inhibitor. Finally, TGF-ß-treated cells significantly increased TGF-ß secretion levels, and their production was inhibited by IL-1ß receptor antagonist treatment. In conclusion, TGF-ß may represent an endogenous danger signal to the active NLRP3 inflammasome, by which IL-1ß mediates TGF-ß expression in an autocrine manner. Therefore, targeting the NLRP3 inflammasome may be a promising approach for the development of therapies for TGF-ß-induced liver fibrosis.


Asunto(s)
Inflamasomas , Factor de Crecimiento Transformador beta , Células Estrelladas Hepáticas/metabolismo , Humanos , Inflamasomas/metabolismo , Inflamación/metabolismo , Interleucina-1beta/antagonistas & inhibidores , Interleucina-1beta/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Factor de Crecimiento Transformador beta/metabolismo
2.
Aging Cell ; 18(2): e12895, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30609251

RESUMEN

Aging is a major risk factor for many chronic diseases due to increased vulnerability to external stress and susceptibility to disease. Aging is associated with metabolic liver disease such as nonalcoholic fatty liver. In this study, we investigated changes in lipid metabolism during aging in mice and the mechanisms involved. Lipid accumulation was increased in liver tissues of aged mice, particularly cholesterol. Increased uptake of both cholesterol and glucose was observed in hepatocytes of aged mice as compared with younger mice. The mRNA expression of GLUT2, GK, SREBP2, HMGCR, and HMGCS, genes for cholesterol synthesis, was gradually increased in liver tissues during aging. Reactive oxygen species (ROS) increase with aging and are closely related to various aging-related diseases. When we treated HepG2 cells and primary hepatocytes with the ROS inducer, H2 O2 , lipid accumulation increased significantly compared to the case for untreated HepG2 cells. H2 O2 treatment significantly increased glucose uptake and acetyl-CoA production, which results in glycolysis and lipid synthesis. Treatment with H2 O2 significantly increased the expression of mRNA for genes related to cholesterol synthesis and uptake. These results suggest that ROS play an important role in altering cholesterol metabolism and consequently contribute to the accumulation of cholesterol in the liver during the aging process.


Asunto(s)
Envejecimiento , Colesterol/metabolismo , Metabolismo de los Lípidos , Hígado/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Animales , Glucosa/metabolismo , Células Hep G2 , Hepatocitos/citología , Hepatocitos/metabolismo , Humanos , Lípidos/análisis , Hígado/citología , Masculino , Ratones , Ratones Endogámicos C57BL , Especies Reactivas de Oxígeno/análisis , Células Tumorales Cultivadas
3.
J Cell Mol Med ; 22(10): 5165-5169, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30019838

RESUMEN

Mesenchymal stem cells (MSCs) have been investigated to treat liver diseases, but the efficiency of MSCs to treat chronic liver diseases is conflicting. FGF21 can reduce inflammation and fibrosis. We established FGF21-secreting adipose derived stem cells (FGF21_ADSCs) to enhance the effects of ADSCs and transplanted them into thioacetamide (TAA)-induced liver fibrosis mice via the tail vein. Transplantation of FGF21_ADSCs significantly improved liver fibrosis by decreasing serum hyaluronic acid and reducing the expression of fibrosis-related factors such as α-smooth muscle actin (α-SMA), collagen and tissue inhibitor of metalloproteinase-1 (TIMP-1) compared with the Empty_ADSCs by inhibition of p-JNK, NF-κB and p-Smad2/3 signalling. α-lactoalbumin (LA) and lactotransferrin (LTF), secretory factors produced from FGF21_ADSCs inhibited TGF-ß1-induced expression of α-SMA and collagen in LX-2 cells. These results suggest that transplantation of FGF21_ADSCs inhibited liver fibrosis more effectively than Empty_ADSCs, possibly via secretion of α-LA and LTF.


Asunto(s)
Factores de Crecimiento de Fibroblastos/genética , Cirrosis Hepática/terapia , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/metabolismo , Actinas/genética , Animales , Colágeno/genética , Factores de Crecimiento de Fibroblastos/uso terapéutico , Células Estrelladas Hepáticas , Humanos , Lactalbúmina/genética , Lactoferrina/genética , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática/genética , Cirrosis Hepática/patología , Ratones , Transducción de Señal/genética , Tioacetamida/toxicidad , Inhibidor Tisular de Metaloproteinasa-1/genética , Factor de Crecimiento Transformador beta1/genética
4.
Int J Mol Sci ; 19(6)2018 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-29882916

RESUMEN

Mature skeletal muscle cells cannot be expanded in culture systems. Therefore, it is difficult to construct an in vitro model for muscle diseases. To establish an efficient protocol for myogenic differentiation of human adipose tissue-derived stem cells (hADSCs), we investigated whether addition of IL-6 and/or myocyte-conditioned media (CM) to conventional differentiation media can shorten the differentiation period. hADSCs were differentiated to myocytes using the conventional protocol or modified with the addition of 25 pg/mL IL-6 and/or C2C12 CM (25% v/v). The expression of MyoD and myogenine mRNA was significantly higher at 5⁻6 days after differentiation using the modified protocol than with the conventional protocol. mRNA and protein expression of myosin heavy chain, a marker of myotubes, was significantly upregulated at 28 and 42 days of differentiation using the modified protocol, and the level achieved after a 4-week differentiation period was similar to that achieved at 6 weeks using the conventional protocol. The expression of p-STAT3 was significantly increased when the modified protocol was used. Similarly, addition of colivelin, a STAT3 activator, instead of IL-6 and C2C12 CM, promoted the myogenic differentiation of ADSCs. The modified protocol improved differentiation efficiency and reduced the time required for differentiation of myocytes. It might be helpful to save cost and time when preparing myocytes for cell therapies and drug discovery.


Asunto(s)
Tejido Adiposo/citología , Diferenciación Celular/efectos de los fármacos , Medios de Cultivo Condicionados/farmacología , Interleucina-6/farmacología , Desarrollo de Músculos/efectos de los fármacos , Factor de Transcripción STAT3/metabolismo , Células Madre/metabolismo , Animales , Células Cultivadas , Humanos , Ratones , ARN Mensajero/genética , ARN Mensajero/metabolismo , Factor de Transcripción STAT3/efectos de los fármacos
5.
Nutrients ; 9(8)2017 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-28767064

RESUMEN

The Psoralea corylifolia L. seed (PCS) is a widely used herbal medicine, but its possible effect against diabetic nephropathy has not been studied. To investigate the anti-nephropathic effect of PCS extracts, we performed experiments using a diabetic mouse model and high glucose-treated mesangial cells. Streptozotocin (STZ)-induced diabetic mice were orally administered PCS extract for 8 weeks (500 mg/kg/day). Increased creatinine clearance, urine volume, urine microalbumin, and mesangial expansion were observed in STZ-induced diabetic mice; these were significantly reduced by PCS extract administration. PCS extract significantly reduced fibrosis in the kidney tissue of diabetic mice as evidenced by decreased mRNA expression of collagen type IV-α2, fibronectin, PAI-1, and TGF-ß1. In addition, cleaved PARP, an apoptotic gene, was upregulated in the diabetic nephropathy mice, and this was ameliorated after PCS extract treatment. Treatment of high glucose-treated MES-13 cells with isopsoralen and psoralen, major components of PCS extract, also decreased the expression of fibrosis and apoptosis marker genes and increased cell viability. PCS extract exerts protective effects against STZ-induced diabetic nephropathy via anti-fibrotic and anti-apoptotic effects. PCS extract might be a potential pharmacological agent to protect against high glucose-induced renal damage under diabetic conditions.


Asunto(s)
Nefropatías Diabéticas/prevención & control , Fibrosis/prevención & control , Extractos Vegetales/farmacología , Psoralea/química , Semillas/química , Animales , Apoptosis/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos C57BL , Fitoterapia , Plantas Medicinales , Estreptozocina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA